Code Story
Code Story

Mentorcam March - Edvard Engeseath

Mentorcam - Book your mentor session with promo code CODE for 20% off! Topic: Angel Investing Dr. Edvard "Eddie" Engeseath, MD is the Co-founder of a tele-health startup Nurx, angel investor, startup advisor, and a former family physician. He founded Nurx to make prescription birth control

Featured Speakers

Noah Labhart - Startup Founder & CTO HostEdvard Anguseth Guest

Topics Discussed

Episode Summary

Executive Summary: The episode explains angel investing through the lens of founder-turned-angel investor Edvard Anguseth, who argues that early-stage investing is fundamentally about backing exceptional people when capital is scarce. He contrasts angels with VCs, discusses how to evaluate startups with limited diligence, and offers practical guidance on finding deals through networks, syndicates, and platforms like AngelList.

Main Topics: Edvard Anguseth’s background and startup origin story (Priority: 5/5): Edvard shares his medical training in Norway, his move from clinical practice into entrepreneurship, and how solving a birth-control access problem led to co-founding Nurex. What angel investing is (Priority: 5/5): He defines angel investing as early-stage startup investing, usually the first outside money into a company, characterized by high risk and potentially high reward. Angels vs. venture capital (Priority: 4/5): The conversation compares angels and VCs in terms of return expectations, check sizes, diligence depth, and investor behavior at different startup stages. How angels choose investments (Priority: 5/5): Edvard emphasizes founder quality, company mission, personal conviction, and pattern recognition over formal financial diligence at the earliest stage. Check sizes, returns, and risk (Priority: 4/5): He outlines typical angel investment ranges and explains why the upside can be extreme if a small number of investments succeed. How to find angel deals (Priority: 5/5): He recommends networking, joining syndicates, using AngelList, and directly reaching out to founders, especially for newcomers.

Key Arguments: Angel investing is the first-money-in stage of startup financing, where risk is high because most companies fail, but a few successes can generate outsized returns. Compared with VCs, angels often accept lower target returns and rely less on formal diligence because early-stage data is limited or nonexistent. At the earliest stage, founder quality matters more than the exact business model; exceptional founders can adapt and solve problems as they go. Personal conviction is important for angel investors because many are motivated by supporting founders they believe in and want to help through hard moments. New angels should not wait for perfect access or perfect data; they should learn through networks, syndicates, and direct outreach to founders. Platforms like AngelList and deal structures like SPVs can help outsiders access startup investments without sourcing deals independently. Edvard’s own founder experience makes him especially sympathetic to startup fundraising challenges and more inclined to back founders early.

Data Points: Years worked as a doctor: About 1.5 years - Edvard worked clinically after medical training before moving into startups. Healthcare rotations: Half a year family medicine, half a year internal medicine, half a year surgery - He describes the structure of his medical training in Norway. Countries where birth control is over the counter: More than 100 countries - He cites this while explaining why access could be improved. Unintended pregnancies in the U.S.: 2.8 million per year - Used to illustrate the scale of the contraception-access problem. Women living in contraceptive deserts: 19.5 million - Shows the market need Nurex aimed to address. VC return expectations: 25% to 35% - He describes typical VC return targets. Angel return expectations: About 20% to 25% (average about 22%) - He contrasts angel expectations with VC targets. Typical angel check size: $10,000 to $50,000+ - He describes the common range he has seen for angel investments. Personal portfolio allocation: 98% in startups - Edvard says he puts nearly all of his money into startups, which he does not recommend.

Pivotal Quotes: "Angel investing is early stage startup investing." — Edvard Anguseth: He gives a plain-language definition of the term when asked what angel investing means. "The number one thing when you're investing this early is the people behind it. That is everything." — Edvard Anguseth: He explains what matters most when deciding whether to back a startup with limited diligence. "If you don't know too much and you want to learn, try to network your way to someone who does this and become part of their syndicate." — Edvard Anguseth: He advises beginners on how to access deals and learn angel investing.

Implications: For founders, angel investors can be crucial early champions; for listeners, the episode shows that angel investing is relationship-driven, founder-focused, and best learned through networks rather than theory alone.

🔓 Sign Up for Unlimited Episode Search

About Code Story

Code Story is a podcast featuring startup founders, tech leaders, CTO's, CEO's, and software architects, reflecting on their human story in creating world changing innovation, disruptive digital products. Their tech. Their products. Their stories.

View all episodes from Code Story